111 related articles for article (PubMed ID: 29024245)
1. hace1 Influences zebrafish cardiac development via ROS-dependent mechanisms.
Razaghi B; Steele SL; Prykhozhij SV; Stoyek MR; Hill JA; Cooper MD; McDonald L; Lin W; Daugaard M; Crapoulet N; Chacko S; Lewis SM; Scott IC; Sorensen PHB; Berman JN
Dev Dyn; 2018 Feb; 247(2):289-303. PubMed ID: 29024245
[TBL] [Abstract][Full Text] [Related]
2. Hace1 controls ROS generation of vertebrate Rac1-dependent NADPH oxidase complexes.
Daugaard M; Nitsch R; Razaghi B; McDonald L; Jarrar A; Torrino S; Castillo-Lluva S; Rotblat B; Li L; Malliri A; Lemichez E; Mettouchi A; Berman JN; Penninger JM; Sorensen PH
Nat Commun; 2013; 4():2180. PubMed ID: 23864022
[TBL] [Abstract][Full Text] [Related]
3. Loss of the tumor suppressor Hace1 leads to ROS-dependent glutamine addiction.
Cetinbas N; Daugaard M; Mullen AR; Hajee S; Rotblat B; Lopez A; Li A; DeBerardinis RJ; Sorensen PH
Oncogene; 2015 Jul; 34(30):4005-10. PubMed ID: 25284589
[TBL] [Abstract][Full Text] [Related]
4. HACE1 is a potential tumor suppressor in osteosarcoma.
El-Naggar AM; Clarkson PW; Negri GL; Turgu B; Zhang F; Anglesio MS; Sorensen PH
Cell Death Dis; 2019 Jan; 10(1):21. PubMed ID: 30622235
[TBL] [Abstract][Full Text] [Related]
5. The tumour suppressor HACE1 controls cell migration by regulating Rac1 degradation.
Castillo-Lluva S; Tan CT; Daugaard M; Sorensen PH; Malliri A
Oncogene; 2013 Mar; 32(13):1735-42. PubMed ID: 22614015
[TBL] [Abstract][Full Text] [Related]
6. The E3 ubiquitin-ligase HACE1 catalyzes the ubiquitylation of active Rac1.
Torrino S; Visvikis O; Doye A; Boyer L; Stefani C; Munro P; Bertoglio J; Gacon G; Mettouchi A; Lemichez E
Dev Cell; 2011 Nov; 21(5):959-65. PubMed ID: 22036506
[TBL] [Abstract][Full Text] [Related]
7. The E3 ubiquitin ligase Hace1 is required for early embryonic development in Xenopus laevis.
Iimura A; Yamazaki F; Suzuki T; Endo T; Nishida E; Kusakabe M
BMC Dev Biol; 2016 Sep; 16(1):31. PubMed ID: 27653971
[TBL] [Abstract][Full Text] [Related]
8. HACE1 negatively regulates neuroinflammation through ubiquitylating and degrading Rac1 in Parkinson's disease models.
Zang CX; Wang L; Yang HY; Shang JM; Liu H; Zhang ZH; Ju C; Yuan FY; Li FY; Bao XQ; Zhang D
Acta Pharmacol Sin; 2022 Feb; 43(2):285-294. PubMed ID: 34593974
[TBL] [Abstract][Full Text] [Related]
9. HACE1 blocks HIF1α accumulation under hypoxia in a RAC1 dependent manner.
Turgu B; Zhang F; El-Naggar A; Negri GL; Kogler M; Tortola L; Johnson F; Ng T; Li A; Yapp D; Lockwood W; Martinez D; Maris JM; Daugaard M; Penninger JM; Hughes CS; Sorensen PH
Oncogene; 2021 Mar; 40(11):1988-2001. PubMed ID: 33603169
[TBL] [Abstract][Full Text] [Related]
10. HACE1-dependent protein degradation provides cardiac protection in response to haemodynamic stress.
Zhang L; Chen X; Sharma P; Moon M; Sheftel AD; Dawood F; Nghiem MP; Wu J; Li RK; Gramolini AO; Sorensen PH; Penninger JM; Brumell JH; Liu PP
Nat Commun; 2014 Mar; 5():3430. PubMed ID: 24614889
[TBL] [Abstract][Full Text] [Related]
11. Loss of the E3 ubiquitin ligase HACE1 results in enhanced Rac1 signaling contributing to breast cancer progression.
Goka ET; Lippman ME
Oncogene; 2015 Oct; 34(42):5395-405. PubMed ID: 25659579
[TBL] [Abstract][Full Text] [Related]
12. Loss of the Tumor Suppressor HACE1 Contributes to Cancer Progression.
Li JC; Chang X; Chen Y; Li XZ; Zhang XL; Yang SM; Hu CJ; Zhang H
Curr Drug Targets; 2019; 20(10):1018-1028. PubMed ID: 30827236
[TBL] [Abstract][Full Text] [Related]
13. Identification of cancer-associated missense mutations in hace1 that impair cell growth control and Rac1 ubiquitylation.
Andrio E; Lotte R; Hamaoui D; Cherfils J; Doye A; Daugaard M; Sorensen PH; Bost F; Ruimy R; Mettouchi A; Lemichez E
Sci Rep; 2017 Mar; 7():44779. PubMed ID: 28317937
[TBL] [Abstract][Full Text] [Related]
14. Expression dynamics of NADPH oxidases during early zebrafish development.
Weaver CJ; Leung YF; Suter DM
J Comp Neurol; 2016 Jul; 524(10):2130-41. PubMed ID: 26662995
[TBL] [Abstract][Full Text] [Related]
15. The HACE1 E3 ligase mediates RAC1-dependent control of mTOR signaling complexes.
Turgu B; El-Naggar A; Kogler M; Tortola L; Zhang HF; Hassan M; Lizardo MM; Kung SH; Lam W; Penninger JM; Sorensen PH
EMBO Rep; 2023 Dec; 24(12):e56815. PubMed ID: 37846480
[TBL] [Abstract][Full Text] [Related]
16. HACE1 Prevents Lung Carcinogenesis via Inhibition of RAC-Family GTPases.
Kogler M; Tortola L; Negri GL; Leopoldi A; El-Naggar AM; Mereiter S; Gomez-Diaz C; Nitsch R; Tortora D; Kavirayani AM; Gapp BV; Rao S; Uribesalgo I; Hoffmann D; Cikes D; Novatchkova M; Williams DA; Trent JM; Ikeda F; Daugaard M; Hagelkruys A; Sorensen PH; Penninger JM
Cancer Res; 2020 Jul; 80(14):3009-3022. PubMed ID: 32366477
[TBL] [Abstract][Full Text] [Related]
17. Differential expression of a novel ankyrin containing E3 ubiquitin-protein ligase, Hace1, in sporadic Wilms' tumor versus normal kidney.
Anglesio MS; Evdokimova V; Melnyk N; Zhang L; Fernandez CV; Grundy PE; Leach S; Marra MA; Brooks-Wilson AR; Penninger J; Sorensen PH
Hum Mol Genet; 2004 Sep; 13(18):2061-74. PubMed ID: 15254018
[TBL] [Abstract][Full Text] [Related]
18. Structural Basis for the Enzymatic Activity of the HACE1 HECT-Type E3 Ligase Through N-Terminal Helix Dimerization.
Singh S; Machida S; Tulsian NK; Choong YK; Ng J; Shankar S; Liu Y; Chandiramani KV; Shi J; Sivaraman J
Adv Sci (Weinh); 2023 Sep; 10(27):e2207672. PubMed ID: 37537642
[TBL] [Abstract][Full Text] [Related]
19. Tumor-suppressive role of HACE1 in hepatocellular carcinoma and its clinical significance.
Gao ZF; Wu YN; Bai ZT; Zhang L; Zhou Q; Li X
Oncol Rep; 2016 Dec; 36(6):3427-3435. PubMed ID: 27805249
[TBL] [Abstract][Full Text] [Related]
20. HACE1 is essential for astrocyte mitochondrial function and influences Huntington disease phenotypes in vivo.
Ehrnhoefer DE; Southwell AL; Sivasubramanian M; Qiu X; Villanueva EB; Xie Y; Waltl S; Anderson L; Fazeli A; Casal L; Felczak B; Tsang M; Hayden MR
Hum Mol Genet; 2018 Jan; 27(2):239-253. PubMed ID: 29121340
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
